Actively Recruiting

Age: 18Years +
All Genders
NCT05597709

Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China

Led by Wuxi Hisky Medical Technology Co Ltd · Updated on 2022-10-28

2900

Participants Needed

1

Research Sites

256 weeks

Total Duration

On this page

Sponsors

W

Wuxi Hisky Medical Technology Co Ltd

Lead Sponsor

Z

Zhongda Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

In 2019, the number of patients with diabetes was about 463 million in the world, accounting for 8.3% of the total population, and it is expected to rise to 578 million (9.2%) by 2030 and 700 million (9.6%) by 2045. According to the WHO diagnostic criteria, the prevalence of diabetes among adults in China from 2015 to 2017 was 11.2%, of which over 90% were type 2 diabetes mellitus (T2DM). The global prevalence of non-alcoholic fatty liver disease (NAFLD) is also very high, which was approximately 25% in 2016. The prevalence of NAFLD may continue to rise. NAFLD is often accompanied by clinical manifestations of metabolic syndrome, such as obesity, T2DM, hyperlipidemia and hypertension.

CONDITIONS

Official Title

Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with type 2 diabetes mellitus according to Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes
  • Underwent ultrasound attenuation parameter measurement using iLivTouch
  • Willing to participate in the study and able to provide written informed consent
Not Eligible

You will not qualify if you...

  • Diagnosed with any type of diabetes other than type 2 diabetes mellitus
  • Unable to attend regular follow-up visits

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zhongda Hospital, Medical School, Southeast University

Nanjing, Jiangsu, China

Actively Recruiting

Loading map...

Research Team

L

Ling Li, Professor

CONTACT

W

Weixia Sun

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here